Vireo Growth Inc. (VREOF) stock
VREOFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/30
$9.01+0.01 (+0.11%)
Close on Oct 19, 2026Market cap $406.23MP/E –Yield –
Vireo Growth operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Vireo Growth's operating income for the twelve months ending Jun 30, 2026 was $1.69M, down 43.7% year over year. For fiscal 2025 it was -$1.05M, down 107.7% from the year before. The highest annual figure on record is $13.56M in fiscal 2024.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$1.05M | -107.7% |
| FY2024 | Dec 31, 2024 | $13.56M | +28.2% |
| FY2023 | Dec 31, 2023 | $10.58M | – |
| FY2022 | Dec 31, 2022 | -$6.94M | – |
| FY2021 | Dec 31, 2021 | -$20.48M | – |
| FY2020 | Dec 31, 2020 | -$23.04M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$6.30M | – |
| Q1 FY2026 | Mar 31, 2026 | $9.00M | +350.0% |
| Q4 FY2025 | Dec 31, 2025 | -$1.81M | – |
| Q3 FY2025 | Sep 30, 2025 | $808.96K | -79.0% |
| Q2 FY2025 | Jun 30, 2025 | -$2.00M | -134.5% |
| Q1 FY2025 | Mar 31, 2025 | $2.00M | -58.0% |
| Q4 FY2024 | Dec 31, 2024 | -$841.55K | -115.6% |
| Q3 FY2024 | Sep 30, 2024 | $3.85M | -34.4% |
| Q2 FY2024 | Jun 30, 2024 | $5.79M | – |
| Q1 FY2024 | Mar 31, 2024 | $4.76M | +1191.6% |
| Q4 FY2023 | Dec 31, 2023 | $5.38M | +666.9% |
| Q3 FY2023 | Sep 30, 2023 | $5.87M | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.04M | -438.1% |
| Q1 FY2023 | Mar 31, 2023 | $368.51K | – |
| Q4 FY2022 | Dec 31, 2022 | $701.77K | – |
| Q3 FY2022 | Sep 30, 2022 | -$189.16K | – |
| Q2 FY2022 | Jun 30, 2022 | $308.19K | – |
| Q1 FY2022 | Mar 31, 2022 | -$7.76M | – |
| Q4 FY2021 | Dec 31, 2021 | -$8.26M | – |
| Q3 FY2021 | Sep 30, 2021 | -$4.13M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.25M | – |
| Q1 FY2021 | Mar 31, 2021 | -$4.84M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.23M | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.27M | – |
| Q2 FY2020 | Jun 30, 2020 | -$12.05M | – |
| Q1 FY2020 | Mar 31, 2020 | -$6.49M | – |
See a number that looks wrong?